OSLO, Norway–(BUSINESS WIRE)–StrongPoint ASA (ticker: STRO), a leading grocery retail technology provider, has been chosen to…
Autor: Press Room
35 years of experience in the field of communications specialized in various business areas, such as administration, marketing, writing, public relations and more.
Shippeo Announces Record $40m Funding Round to Accelerate Global Supply Chain Resilience
PARIS–(BUSINESS WIRE)–#Fundraising—Shippeo, a global leader in real-time multimodal supply chain transportation visibility, today announced a record-breaking…
Proemion Announces €33.5M Growth Investment from Global Technology Investment Firm Battery Ventures
Proemion will use funds to expand telematics technology globally, move into new markets and pursue acquisitions…
Beckley Psytech Strengthens Pipeline and Development Team With Acquisition of Eleusis Therapeutics Limited
All equity acquisition adds short-acting psilocin candidate for broad range of indications to Beckley Psytech’s portfolio…
Digital Construction Works Announces Availability of JDLink Connectivity with the DCW Integrations Platform
New connection now available in both John Deere and DCW Integrations Marketplaces MUNICH–(BUSINESS WIRE)–#civilconstruction–Digital Construction Works…
Gilead Presents Real-World Evidence Reinforcing the Use of Biktarvy® for the Treatment of People Living With HIV With a Range of Comorbidities
– New Clinical Outcomes from BICSTaR Study Show Sustained Impact of Biktarvy for People with HIV…
Juniper Research: 5G Service Revenue to Reach $315 Billion Globally in 2023; Representing 35% of Operators’ Total Revenue
BASINGSTOKE, England–(BUSINESS WIRE)–#5gindustry–A new study from Juniper Research has found operator‑billed 5G service revenue will reach…
CORRECTING and REPLACING Humana Announces Major Expansion of Florida Dental Network, Benefits
In addition to doubling the number of dentists available to its Medicare Advantage members, Humana is…
Merck’s PREVYMIS™ Demonstrates Efficacy in Phase 3 Study for Prevention of Cytomegalovirus Disease in Adults After Kidney Transplantation
PREVYMIS showed non-inferior efficacy and more favorable safety profile compared to standard of care; results presented…
New Real-World Analysis of TEPEZZA® (teprotumumab-trbw) Use Indicates a Small Percentage of People Receive a Second Course of Treatment
— Analysis presented at American Thyroid Association Annual Meeting (ATA 2022) shows during a two-year period,…